Author + information
- Received April 13, 2011
- Revision received June 29, 2011
- Accepted July 7, 2011
- Published online November 1, 2011.
- Jan Van der Heyden, MD⁎,⁎ (, )
- Danihel Van Neerven⁎,
- Uday Sonker, MD†,
- Egbert T. Bal, MD⁎,
- Johannes C. Kelder, MD⁎,
- Herbert W.M. Plokker, MD, PhD⁎ and
- Maarten J. Suttorp, MD, PhD⁎
- ↵⁎Reprint requests and correspondence:
Dr. Jan Van der Heyden, Department of Cardiology, St-Antonius Hospital, Koekoekslaan 1 3430 EM, Nieuwegein, the Netherlands
Objectives The purpose of this study was to evaluate the feasibility and safety of the combined outcome of carotid artery stenting (CAS) and coronary artery bypass graft (CABG) surgery in neurologically symptomatic patients.
Background The risk of perioperative stroke in patients undergoing CABG who report a prior history of transient ischemic attack or stroke has been associated with a 4-fold increased risk as compared to the risk for neurologically asymptomatic patients. It seems appropriate to offer prophylactic carotid endarterectomy to neurologically symptomatic patients who have significant carotid artery disease and are scheduled for CABG. The CAS-CABG outcome for symptomatic patients remains underreported, notwithstanding randomized data supporting CAS for high-risk patients.
Methods In a prospective, single-center study, the periprocedural and long-term outcomes of 57 consecutive patients who underwent CAS before cardiac surgery were analyzed.
Results The procedural success rate of CAS was 98%. The combined death, stroke, and myocardial infarction rate was 12.3%. The death and major stroke rate from time of CAS to 30 days after cardiac surgery was 3.5%. The myocardial infarction rate from time of CAS to 30 days after cardiac surgery was 1.5%.
Conclusions This is the first single-center study reporting the combined outcome of CAS-CABG in symptomatic patients. The periprocedural complication rate and long-term results of the CAS-CABG strategy in this high-risk population support the reliability of this approach. In such a high-risk population, this strategy might offer a valuable alternative to the combined surgical approach; however, a large randomized trial is clearly warranted.
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received April 13, 2011.
- Revision received June 29, 2011.
- Accepted July 7, 2011.
- American College of Cardiology Foundation